This analysis aimed to be aware of the prospective partnership concerning HGF levels and Parkinson’s ailment, contributing on the broader understanding of the ailment’s pathophysiology and likely biomarkers. Dihexa’s molecular structure will allow it to cross the blood-Mind barrier effectively, enabling superior bioavailability compared to